Early and frequent development of ocular hypertension in children with nephrotic syndrome

Emi Kawaguchi(Tokyo Metropolitan Children's Medical Center), Masataka Honda(Rikkyo University), Yuko Hamasaki(Toho University), Tomoyuki Sakai(Tokyo Metropolitan Children's Medical Center), Yoshihiko Morikawa(Tokyo Metropolitan Children's Medical Center), Yoshinobu Nagaoka(Seoul National University Children's Hospital), Eiichiro Noda(Tokyo Metropolitan Children's Medical Center), Hiroshi Hataya(Japanese Society for Dialysis Therapy), Kenji Ishikura(Kitasato University), Masaru Miura(Tokyo Metropolitan Children's Medical Center), Takashi Ando(Japan Clinical Cancer Research Organization), Riku Hamada
Pediatric Nephrology
May 23, 2014
10.1007/s00467-014-2848-x
Cited by 13

Related Papers

Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial
|The Lancet|2014|450
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|278
Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease
|Clinical and Experimental Nephrology|2013|267
Epidemiology of pediatric chronic kidney disease/kidney failure: learning from registries and cohort studies
|Pediatric Nephrology|2021|149
A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment
|Kidney International|2014|135